Cardiovascular–kidney–metabolic syndrome: novel molecular mechanism and glucagon-like peptide-1-targeting therapy
- DOI
- 10.3389/fcell.2026.1996288
- Published
- 2026-10-23
- Container
- Frontiers in Cell and Developmental Biology
- Publisher
- Frontiers Media SA
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.3389/fcell.2026.1996288,
title = {Cardiovascular–kidney–metabolic syndrome: novel molecular mechanism and glucagon-like peptide-1-targeting therapy},
author = {Fengzhao Liu and Zihan Xu and Wenru Wang and Junwei Gao and Changgeng Fu and Peng Liu},
year = {2026},
journal = {Frontiers in Cell and Developmental Biology},
doi = {10.3389/fcell.2026.1996288},
url = {https://doi.org/10.3389/fcell.2026.1996288}
}RIS
TY - JOUR TI - Cardiovascular–kidney–metabolic syndrome: novel molecular mechanism and glucagon-like peptide-1-targeting therapy AU - Fengzhao Liu AU - Zihan Xu AU - Wenru Wang AU - Junwei Gao AU - Changgeng Fu AU - Peng Liu PY - 2026 JO - Frontiers in Cell and Developmental Biology DO - 10.3389/fcell.2026.1996288 UR - https://doi.org/10.3389/fcell.2026.1996288 ER -
APA
Liu, F., Xu, Z., Wang, W., Gao, J., Fu, C., & Liu, P. (2026). Cardiovascular–kidney–metabolic syndrome: novel molecular mechanism and glucagon-like peptide-1-targeting therapy. Frontiers in Cell and Developmental Biology. https://doi.org/10.3389/fcell.2026.1996288
Source records
- crossref · retrieved 2026-11-10T08:15:00.131Z